CN Patent
CN102793925B — 一种由羟丙基纤维素和乳糖组成的药用预混剂
Assigned to Tianjin Hongri Aileyi Pharmaceutical Adjuvant Co ltd · Expires 2014-03-05 · 12y expired
What this patent protects
本发明公开了一种由羟丙基纤维素和乳糖组成的药用预混剂,属于药物制剂技术领域,其特征在于,预混剂的成分为羟丙基纤维素和乳糖,二者的质量份数为羟丙基纤维素∶乳糖=10~90∶90~10,其混合方法是物理混合;本发明得到的预混剂可以使大多数药物按照要求的速率释放。
USPTO Abstract
本发明公开了一种由羟丙基纤维素和乳糖组成的药用预混剂,属于药物制剂技术领域,其特征在于,预混剂的成分为羟丙基纤维素和乳糖,二者的质量份数为羟丙基纤维素∶乳糖=10~90∶90~10,其混合方法是物理混合;本发明得到的预混剂可以使大多数药物按照要求的速率释放。
Drugs covered by this patent
- Imitrex (SUMATRIPTAN) · GSK
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.